| This week's sponsor is CMIC Group. | |  | Partner with Japan’s Largest CRO for your global drug development
CMIC is the largest CRO in Japan, with extended services in drug development and GMP manufacturing, site management, regulatory consulting and contract sales. We have the full end to end solution to help you enter Japan market and fulfill your drug development and manufacturing needs in US, Japan and Asia.
To learn more, click here. |
Today's Rundown Featured Story | | | Tuesday, January 15, 2019 Immunocore has named David Berman as its head of research and development. Berman spent the past decade overseeing the rise of immuno-oncology drugs at AstraZeneca and Bristol-Myers Squibb. |
|
|
| This week's sponsor is Sprout BioVentures. | |  | Announcing the Golden Sprout Competition
High-potential start-ups are encouraged to apply for the Golden Sprout Award. Winners receive 6 months of chemistry support (2 FTEs) at no cost. Application period closes February 28, 2019. Click here for more information. |
Top Stories Tuesday, January 15, 2019 Another day, another Big Pharma executive jumping ship to biotech. On Tuesday morning, it was Omar Khwaja, M.D., Ph.D., who became chief medical officer at gene therapy specialist Voyager Therapeutics. Tuesday, January 15, 2019 While the high cost of living in San Francisco has famously grabbed headlines, the costs of simply meeting there, even for a few days, are becoming untenable for some. Tuesday, January 15, 2019 Aimmune Therapeutics has confirmed that the government shutdown will delay the FDA’s review of AR101, its oral immunotherapy for peanut allergy. Tuesday, January 15, 2019 Seres Therapeutics is promoting its chief operating and financial officer, Eric Shaff, to succeed Roger Pomerantz as its new president and CEO. Tuesday, January 15, 2019 The EMA has increased its forecast of the proportion of staff that will relocate with it to Amsterdam. Buoyed by the improved outlook, the agency has predicted its core drug evaluation activities will be unaffected by the Brexit-enforced move. Tuesday, January 15, 2019 The New Year wanderlust continues as Paul Streck, M.D., will this week exit his role as chief medical officer of Insmed to "pursue an employment opportunity on the West Coast." Resources Sponsored by: Outer Edge Technology Learn how to cost-effectively accelerate time to market by selecting a Life Sciences focused MSP that designs and manages cloud-based infrastructures by typically leveraging Private, AWS and Azure platforms. Sponsored by: DeciBio Consulting With the liquid biopsy market maturing and >80 companies still competing with liquid biopsy offerings, it is crucial for investors to be able to cut through the noise and identify the winners. Presented by: Veeva Share your thoughts on the life sciences industry's progress in improving study execution. Presented by: Aprecia Get ahead of looming challenges in the market that include both generic products and new branded drugs. Sponsored by: Oracle Health Sciences New infographic shows trends in clinical development and the impact on randomization and trial supply management technology (RTSM). Sponsored by: Veeva Reduce the effort to create submissions and track registrations with a move to unified RIM. Watch the on-demand webinar. Sponsored by: DocuSign Life sciences companies must immediately identify and realize productivity gains to drive down operational costs—or risk seeing more nimble competitors disappear into the distance. Where to begin? Sponsored by: Biotech Primer The Biopharma industry is moving at lightning speed and it can be a challenge to keep pace. Here at Biotech Primer we spend hours each week researching, writing, and editing original content for the Biotech Primer WEEKLY with one goal in mind: to help everyone better understand the latest science and technology driving today’s healthcare industry. | 
